Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL

For questions regarding this product, please see: Full Prescribing Information

The below information is provided in response to your request and may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above.

TRULICITY® (dulaglutide): Dose Escalation

The recommended initiating dose of Trulicity (dulaglutide) is 0.75 mg once weekly and may be increased to 1.5 mg once weekly for additional glycemic control.

Detailed Information

There were no dulaglutide dose adjustments made in clinical trials. Patients were initiated and maintained on either dulaglutide 1.5 mg or dulaglutide 0.75 mg for the duration of the trials.1

In controlled clinical trials, once weekly administration of dulaglutide 1.5 mg or dulaglutide 0.75 mg was effective in improving glycemic control in adults with T2DM. The recommended initiating dose of dulaglutide 

  • is 0.75 mg once weekly, and 

  • may be increased to 1.5 mg once weekly for additional glycemic control.1

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly

Reference

1. Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Glossary

T2DM = type 2 diabetes mellitus

Date of Last Review: January 11, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 8pm ET

Or you can

Ask us a question Chat with us

Submit a question

Visit Us @LillyMedical